What is the risk of developing Subacute Sclerosing Panencephalitis (SSPE) if measles is caught at age 5 or later?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of SSPE When Measles is Caught at Age 5

The statement is correct—SSPE risk is dramatically lower when measles is contracted at age 5 or later, with the highest risk occurring when measles infection happens before age 2 years. 1, 2

Age-Stratified Risk Profile

The risk of developing SSPE is strongly age-dependent at the time of measles infection:

  • Measles infection under 1 year of age carries a risk 16 times greater than measles contracted over age 5 years 2
  • The highest risk occurs in children who contracted measles when they were less than 5 years of age, with 46% of SSPE cases having had measles before age 2 1, 3
  • Measles under 1 year specifically carries an 18-fold increased risk (18 × 10⁻⁵) compared to the baseline risk of 4.0 × 10⁻⁵ for all ages 4

Quantifying the Overall Risk

The baseline risk across all ages is approximately:

  • 4-11 cases per 100,000 measles infections 5, 6, 4, 2
  • This translates to a risk of 4.0 × 10⁻⁵ following measles infection 4
  • However, this substantially underestimates actual risk because only 11% of measles cases are officially reported 6

Critical Clinical Context

The latency period between measles infection and SSPE onset averages 7.0 years, meaning SSPE typically manifests years after the initial infection 3. This interval has been increasing over time due to declining measles incidence from vaccination programs 4.

Prevention Remains Paramount

Measles vaccination is the only effective prevention strategy for SSPE and has essentially eliminated the disease in highly vaccinated populations 7, 5, 8. The risk after vaccination (0.14 × 10⁻⁵) is dramatically lower than after natural infection 4, 2.

Important Caveat

The MMR vaccine does not increase SSPE risk, even in those who previously had measles or prior vaccination 7, 8, 6. When rare SSPE cases occurred in vaccinated children without known measles history, evidence indicates these children likely had unrecognized measles infection before vaccination 7, 8.

References

Guideline

Genetic Predispositions and Prevention Strategies for Subacute Sclerosing Panencephalitis (SSPE)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risk of SSPE When Accounting for Measles Underreporting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Measles Antibody in CSF for SSPE Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.